Reaktionsgleichung
[NH2:1][C:2]1[C:3]([C:7]2[N:11]([C:12]3[CH:17]=[CH:16][C:15]([F:18])=[C:14]([Br:19])[CH:13]=3)[C:10](=[O:20])[O:9][N:8]=2)=[N:4][O:5][N:6]=1.[F:21][C:22]([F:35])([F:34])[C:23]([N:25]1[CH2:30][CH2:29][CH:28]([C:31](Cl)=[O:32])[CH2:27][CH2:26]1)=[O:24]>>[Br:19][C:14]1[CH:13]=[C:12]([N:11]2[C:10](=[O:20])[O:9][N:8]=[C:7]2[C:3]2[C:2]([NH:1][C:31]([CH:28]3[CH2:27][CH2:26][N:25]([C:23](=[O:24])[C:22]([F:35])([F:21])[F:34])[CH2:30][CH2:29]3)=[O:32])=[N:6][O:5][N:4]=2)[CH:17]=[CH:16][C:15]=1[F:18]Komponenten
3
Versuchsvorschrift
This compound was prepared according to the procedure of Example 35 using 3-(4-amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one and 1-(trifluoroacetyl)piperidine-4-carbonyl chloride as the starting materials. LCMS for C18H14BrF4N6O5 (M+H)+: m/z=549.0, 550.9.
Aufarbeitung
- customThis compound was prepared
Quellen und Nachweise
- ORD-Eintrag
- ord-e82c4cfbd1db4928b48afca3f1f64709
- Quelldatensatz
- uspto-grants-2014_09
- Patentnummer
- US08846726B2
Verknüpfte Notizen
Wird geladen…